Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs66712197 | chr14:74418588 | G/A | 4.63E-6 | 173 | 25.17 | 29.7 | 10.43 | KM Plot |
PCPG | rs66715932 | chr17:50333704 | T/G | 0.000426 | 170 | 24.82 | 30.93 | 17.4 | KM Plot |
PCPG | rs6675851 | chr1:243787494 | G/A | 0.000229 | 174 | 25.4 | 25.53 | 18.35 | KM Plot |
PCPG | rs66781959 | chr14:74510612 | G/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs66798475 | chr17:50271048 | G/A | 4.36E-5 | 174 | 25.53 | 29.7 | 14.43 | KM Plot |
PCPG | rs66815943 | chr17:50333646 | G/A | 0.00028 | 170 | 26.12 | 28.38 | 16.33 | KM Plot |
PCPG | rs6687226 | chr1:161891556 | G/T | 3.69E-11 | 178 | 24.62 | 27.33 | 10.3 | KM Plot |
PCPG | rs66896899 | chr14:74480794 | G/C | 3.72E-7 | 178 | 25.28 | 28.38 | 7.4 | KM Plot |
PCPG | rs669009 | chr6:150387302 | A/T | 1.01E-6 | 171 | 1.83 | 24.53 | 26.57 | KM Plot |
PCPG | rs66932813 | chr15:43088622 | T/G | 2.99E-14 | 176 | 25.4 | 24.85 | 3.17 | KM Plot |
PCPG | rs6693526 | chr1:56349764 | G/A | 2.18E-5 | 172 | 25.53 | 27.43 | 13.27 | KM Plot |
PCPG | rs66935820 | chr12:21639194 | T/C | 2.7E-8 | 174 | 25.28 | 26.47 | 2.28 | KM Plot |
PCPG | rs66947001 | chr15:43109142 | AT/A | 2.3E-14 | 177 | 25.47 | 24.85 | 3.17 | KM Plot |
PCPG | rs66955360 | chr16:71467755 | GGAGGCT/G | 0.000139 | 175 | 24.53 | 27.22 | 43.12 | KM Plot |
PCPG | rs66963912 | chr12:113579006 | T/G | 0.000265 | 172 | 25.17 | 24.5 | 39.12 | KM Plot |